Penicillin desensitization correlation of clinical and immunological events using an in vitro model.
D000197:Actinomycosis, Cervicofacial / Q000188:drug therapy; D000818:Animals; D000906:Antibodies; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007271:Injections, Intradermal; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008407:Mast Cells / Q000276:immunology; D008875:Middle Aged; D008954:Models, Biological; D010400:Penicillin G / Q000008:administration & dosage / Q000627:therapeutic use; D010406:Penicillins / Q000008:administration & dosage; D051381:Rats; D012882:Skin Tests; D013411:Sulfadiazine / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000906:Antibodies; D010406:Penicillins; D013411:Sulfadiazine; D013752:Tetracycline; D010400:Penicillin G